Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Sponsorship: Partisan Bill (Republican 19)

Status: (Introduced) 2025-01-23 - Referred to the House Committee on Energy and Commerce. [HB679 Detail]

Text: Latest bill text (Introduced) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2025 US Congress HB679 at this time.